UBS Group AG - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 15 filers reported holding CYCLO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$125
-90.9%
88
-94.6%
0.00%
Q1 2023$1,378
-65.5%
1,640
-41.6%
0.00%
Q4 2022$3,990
+99.5%
2,810
+254.4%
0.00%
Q2 2022$2,000
-71.4%
793
-65.4%
0.00%
Q1 2022$7,000
-85.4%
2,291
-82.3%
0.00%
Q4 2021$48,000
-82.2%
12,911
-67.7%
0.00%
Q3 2021$269,000
+138.1%
39,914
+259.8%
0.00%
Q2 2021$113,000
+1783.3%
11,094
+1489.4%
0.00%
Q1 2021$6,0006980.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Renaissance Technologies 75,787$240,0000.00%
ROYAL BANK OF CANADA 746$2,0000.00%
VANGUARD GROUP INC 255,065$808,0000.00%
UBS Group AG 2,291$7,0000.00%
IFP Advisors, Inc 26$2,0000.00%
WELLS FARGO & COMPANY/MN 2,047$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 48,316$153,0000.00%
STATE STREET CORP 28,300$90,0000.00%
CITIGROUP INC 1,232$4,0000.00%
View complete list of CYCLO THERAPEUTICS INC shareholders